Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$36,004,029
-$25,350,607 QoQ
Shares Held
280,187
-45.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#384
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Sep 30, 2022CallValue
$68,896
CallShares
800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS holds $664,875,786 across 10 Drug Manufacturers - General names. MRK ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
707,790 | $179,757,426 | |
| 2 | LLY |
ELI LILLY & Co
|
133,441 | $160,053,151 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,519,137 | $145,152,673 | |
| 4 | ABBV |
AbbVie Inc.
|
267,055 | $67,201,720 | |
| 5 | NVO |
Novo Nordisk A S
|
824,229 | $39,513,538 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
280,187 | $36,004,029 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
143,928 | $18,183,863 | |
| 8 | PFE |
Pfizer Inc
|
632,317 | $15,226,193 |
All Filings in MRK
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,004,029 | 280,187 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $61,354,636 | 510,056 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,501,340 | 308,772 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $72,962,195 | 869,322 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $47,569,460 | 600,928 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $130,428,281 | 1,453,078 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $34,780,695 | 349,625 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $35,973,536 | 316,780 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $48,965,995 | 395,525 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $171,548,458 | 1,300,102 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $209,100,250 | 1,917,999 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $90,924,719 | 883,193 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,579,524 | 490,333 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $72,252,321 | 679,127 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $107,644,133 | 970,204 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $68,896 | 800 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $274,434,470 | 3,186,652 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,842,030 | 371,197 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $98,372 | 1,079 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $180,180,732 | 2,195,987 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $48,421,151 | 631,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $145,835,453 | 1,941,625 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $171,901,096 | 2,210,378 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $124,921,636 | 1,620,464 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $192,910,570 | 2,358,321 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $67,287,743 | 811,184 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,210,052 | 106,169 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $183,684,632 | 2,387,376 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||